• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • 2.0 LPBI Brochure
  • Coronavirus, SARS-CoV-2 Portal
  • Knowledge PORTALS System (KPS)
  • Journal PharmaceuticalIntelligence.com
  • 2020-21 VISTA 1.0 LPBI
  • LPBI Group’s History
  • 2020-21 VISION – 2.0 LPBI
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • LPBI Group News
  • CALENDAR
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2020 Summer Internship Portal
  • 2021 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Opportunities Map in the Acquisition Arena

Opportunities Map for LPBI Group’s three Intellectual Property Asset Classes of Digital Published Products in the Acquisition Arena

 

The intellectual property of LPBI is of three types: a corpus of curated articles, a corpus of e-books, and a corpus of e-proceedings. This IP is highly relevant to five industries across twelve economic sectors. LPBI has pioneered production of scientific content with unique curation methodology by a highly knowledgeable group of experts. The content and the potential consumers and valuers of this content are represented graphically below. The three types of corpus, together with the very large audience that follows the content on various media, represent intangible assets of LPBI and can be represented as such to potential investors. Together with the tangible assets described below, the combination represents a unique opportunity for acquisition.

 

  • Value Drivers

  • Business Functions

  • Twelve Economic Segments for LPBI Group’s IP – Prospects for Transfer of Ownership

  1.       Holding Companies, Investment Bankers and Private Equity
  2.       Information Technology Companies – Health Care
  3.       Scientific Publishers
  4.       Big Pharma
  5.       Internet Health Care Media & Digital Health
  6.       Online Education
  7.       Health Insurance Companies & HMOs
  8.       Medical and Pharma Associations
  9.       Medical Education
  10.       Information Syndicators
  11.       Global Biotech & Pharmaceutical Conference Organizer
  12.       CRO & CRA

 

Potential Acquirers in Five Economic Sectors and Industries: Financial Sector, Information Technology (IT) Companies, Manufacturing, Education: Private & Public Institutions and Media by Business Function Type & Value Drivers of Three Asset Classes available for Potential Use by Acquirers 

 

List of IP Assets – DIGITAL PUBLISHED PRODUCTS for Technology Transfer of Ownership:

  • IP Asset Class I: The Journal +5,500 Scientific articles

https://lnkd.in/erfbayJ

  • IP Asset Class II: 16 Volumes in BioMed e-Series

https://lnkd.in/ekWGNqA

  • IP Asset Class III: +60 eProceedings of BioTech & Medical Conferences

https://pharmaceuticalintelligence.com/press-coverage/ 

 

UPDATED on 2/15/2020

Business Function:

 

Product Marketing

Business Function: 

 

Product Development

Business Function: 

 

Increasing production capacity by a Horizontal Merger

Value Driver

 

Life science markets need ways to reach influencers – lab managers, PIs, R&D managers. The Markets are extremely competitive, awareness driven, FAD-based, result perception driven, publication oriented.

 

VCs

 

Goldmans and other investment banks

M&A players

Project Banks e.g. Elara Capital

Value Driver

 

(a) Software Application development

(b) product repurposing

(c) Beta Testing or Clinical Trials

(d) innovation orientation

(e) open innovation

(f) trends in value creation

Value Driver

 

(a) Change in Organizational Structure by acquiring economies of scale and increasing capacities for doing same functions in bigger scale

(b) changing trends in value creation and exposures.

(c) trends in new fields of value creation 

(d) drafting concepts in corporate values and company perception  

Financial Sector

 

Holding Companies & Investment Bankers

 

Internet Brands of KKR, Temasek, NMC, Generex

Information Technology Sector:

 

Cloud-based – 

 

Amazon Web Services (AWS),  Alphabet – Verily,     Apple-Health,   IBM Watson

 

Information Technology Sector:

 

Cloud & Server-based – 

 

Microsoft-Health,

Boomi is a business unit acquired by Dell in 2010 that specializes in integration platform as a service (iPaaS),

Oracle-Health, SAP

Intel-Health

 

 

Media 

 

Content-driven:

 

(d) Internet Health Care Media (MedScape, UptoDate)

 

Manufacturing 

 

Big Pharma Drug Production

J&J, Roche, Novartis, Pfizer, Bayer, Merck, GSK, Sanofi, Abbvie, Abbott, Eli Lilly, Amgen, BMS, Gilead, AstraZeneca, TEVA, BI, NovoNordisk, Allergen, Takeda, Shire, Celgene, Biogen

Scientific Publishing Journals & Book Production

 

Wolters Kluwer, Elsevier, John Wiley, CHI

Media 

 

Content-driven:

 

Information Syndicators (Reuters Clarivate & Springer)

Health IT players

 

business trend driven, keyword driven, AI- and productivity driven

Business Function: 

 

Achieving efficiencies of integration of production processes by a Vertical Merger

Business Function: 

 

Application of proprietary Intellectual Property & Knowledge dissemination to Members or event Attendees

Business Function: 

 

Analytics & Discovery:

Text Mining Corpus of Article, Books, e-Proceeding

Value Driver

 

Change in Organization Structure by integration of additional functionality to existing workflows & production processes, capability augmentation by new expertise (R&D, Production, Marketing) via acquisitions

Value Driver

 

(a) Use and creation of creative scientific CONTENT 

(b) changing and influencing the buzz in life sciences, 

(c) running and developing campaigns 

(d) finding new and innovative ground for connecting people

Value Driver

 

(a) Cost containment by new efficiencies

(b) finding new trends and new growth drivers

(c) predicting new trends and Fads and pinpointing future disruptors

Manufacturing 

 

Big Pharma Drug Production

J&J, Roche, Novartis, Pfizer, Bayer, Merck, GSK, Sanofi, Abbvie, Abbott, Eli Lilly, Amgen, BMS, Gilead, AstraZeneca, TEVA, BI, NovoNordisk, Allergen, Takeda, Shire, Celgene, Biogen

Education Private & Public Institutions

 

Medical Education

 

250 Medical Schools in the US & Medical Schools in the European Community

 

Research and innovation institution, nursing and public health schools

Financial Sector

 

Health Care Insurers

 

United Health, Kaiser Permanente & BlueCross/BlueShield, SelectHealth/Intermountain HC

Digital Health industry

hubs, communities, giants

 

e.g. https://www.healthcareglobal.com/technology/top-5-digital-health-giants-you-should-be-watching

Education Private & Public Institutions

 

Online Certifications and Degrees

 

Coursera &

MOOC

Media 

 

Health Care Services (Contract-based Outsourcing)

 

Top 10 on List of Global and US-based CRO & CRA

Government and policy makers

 

topic driven and analytics drived,

Deep insights, analytics, trends and predictive, futuristic, data driven analytics, expert oriented and higher context observation driven. Opinion oriented

Media 

 

Content-driven:

 

(a) Medical and Pharma Associations

(b) Global Biotech & Pharmaceutical Conference Organizers

Health authorities and professional, public health professional

 

UPDATED on 2/12/2020

Three IP Asset Classes: Their Economic Value Potential for

Prospective acquirers

Holding Company and Investment Banker

Potential Use by Acquirer:

Invest in product marketing of three Lines of Business

Class I,II,III

  • Internet Brands of KKR

http://www.kkr.com/

  • Temasek

https://www.temasek.com.sg/en/index.html

  • New Mountain Capital (NMC)

http://www.newmountaincapital.com/

  • Generex

http://www.generex.com/

  • Bain Capital

https://www.baincapital.com/

 

Information Technology Companies – Health Care

Potential Use by Acquirer:

Use contents in application development

Class I,II,III 

  • Amazon Web Services (AWS)
  • Alphabet – Verily
  • Apple Health
  • Microsoft Health
  • IBM-Watson
  • Oracle-Healthcare
  • SAP
  • Illumina

 

Scientific Publishers

Potential Use by Acquirer:

Horizontal merger

Class I,II,III 

  • Wolters Kluwer
  • Elsevier
  • John Wiley
  • CHI

 

Big Pharma

Potential Use by Acquirer:

Vertical Integration with a production factor

Class I,II,III

1. Drug Discovery Process

2. Clinical Trial

3. Drug Repurposing

https://pharmaceuticalintelligence.com/2019/02/14/drug-repurposing-hub-library-broadinstitute-mit-harvard/

  • J&J
  • Roche
  • Novartis
  • Pfizer
  • Bayer
  • Merck
  • GSK
  • Sanofi
  • Abbvie
  • Abbott
  • Eli Lilly
  • Amgen
  • BMS
  • Gilead
  • AstraZeneca
  • TEVA
  • BI
  • NovoNordisk
  • Allergen
  • Takeda
  • Shire
  • Celgene
  • Biogen

 

Internet Health Care Media

 Potential Use by Acquirer:

Horizontal merger

Class I,II,III

  • MedScape

–        676,000 active US Physicians

–        2,000,000 active US HCP’s (non-Physicians)

  • UptoDate

 

Education

Potential Use by Acquirer:

Content is King

Class I,II

  • MOOC
  • Coursera

 

Health Insurance Companies & HMOs

Potential Use by Acquirer:

Optimization of Treatment: Efficacy vs cost of treatment

Class I,II,III

  • United Health
  • Kaiser Permanente
  • BC/BS

 

Medical and Pharma Associations

Potential Use by Acquirer:

Information for Members

Class I,II,III 

  • Chinese College of Cardiology – 350,000 MDs
  • Chinese College of Oncology
  • Germany
  • Japan
  • India
  • Canada

 

  Medical Education

Potential Use by Acquirer:

Content is King

Class I,II,III

  • 250 Medical Schools in the US
  • Europe

In 2019, Class II, e-Books are in Use in Medical Schools in the State of Pennsylvania for curriculum development:

Series A: Volume 3 – Epigenetics, Genetics and Genomics [Jefferson Medical School, Philadelphia]

Series B: Volume 1 –  Genomics & Personalized Medicine [Temple University, Philadelphia]

Series C: Volume 1,2 – Cancer [Temple University, Philadelphia]

Series E: Volume 1 – Voices of Patients  [Jefferson Medical School, Philadelphia]

 

Information Syndicators

Potential Use by Acquirer:

Text Mining

Class I,II,III

  • US – Reuters’ Clarivate

They are operating in the same arena.

They can use our system to other domains.

They can develop it as part of their comprehensive offer.

New connections and ideas they will bring on board.

  • Europe – Springer

 

Global Biotech & Pharmaceutical Conference Organizers

Potential Use by Acquirer:

Information for Attendees

Class I,II,III

  • US – Cambridge Healthtech Institute – Class I,II,III
  • BIO Asia International Conference – BIO
  • CPhI North America 2019 | No.1 Biotech Conference‎
  • 25th Asia Pacific Biotechnology Congress
  • BIO-Europe Spring® | Vienna, Austria. Mar 25-27‎
  • BioTech Conference 2019 London | UK. May 7-8. 

CRO & CRA

Potential Use by Acquirer:

Text Mining for Indication and off label in Clinical Trial Design and After Market Efficacy Monitoring

Class I,II,III 

  • Top 10 on List of CRO in the US
  • Top 10 on List of Global CRO

LPBI Group’s Intellectual Property Potential use by Business Function and by Value Drivers

Business Function:

 

Product Marketing

Business Function:

 

Product Development

Business Function:

 

Increasing production capacity by a Horizontal Merger

Value Driver

 

Revenue generation by penetration of multiple markets simultaneously, exploit economic benefits from internal vertical integration, product differentiation and diversification across product lines and markets

 

Value Driver

 

(a) Software Application development              

(b) product repurposing                     (c) Beta Testing or Clinical Trials

 

Value Driver

 

Change in Organizational Structure by acquiring economies of scale and increasing capacities for doing same functions in bigger scale

 

Financial Sector

 

Holding Companies & Investment Bankers

Internet Brands of KKR, Temasek, NMC, Generex

Information Technology Sector: Cloud-based –

 

Amazon Web Services (AWS),   Alphabet – Verily,   Apple-Health,   IBM Watson

 

Information Technology Sector: Cloud & Server-based –

 

Microsoft, Oracle-Health, SAAP

 

 

Media

Content-driven:

(d) Internet Health Care Media (MedScape, UptoDate)

 

Scientific Publishing Journals & Book Production

 

Wolters Kluwer, Elsevier, John Wiley, CHI

Manufacturing

 

Big Pharma Drug Production

J&J, Roche, Novartis, Pfizer, Bayer, Merck, GSK, Sanofi, Abbvie, Abbott, Eli Lilly, Amgen, BMS, Gilead, AstraZeneca, TEVA, BI, NovoNordisk, Allergen, Takeda, Shire, Celgene, Biogen

 

Media

 

Content-driven:

 

(b) Information Syndicators (Reuters Clarivate & Springer)

 

Business Function:

 

Achieving efficiencies of integration of production processes by a Vertical Merger

Business Function:

 

Application of proprietary Intellectual Property & Knowledge dissemination to Members or event Attendees

 

Business Function:

 

Analytics & Discovery:

Text Mining Corpus of Article, Books, e-Proceeding

 

Value Driver

 

Change in Organization Structure by integration of additional functionality to existing workflows & production processes, capability augmentation by new expertise (R&D, Production, Marketing) via acquisitions

 

Value Driver

 

Use and creation of creative scientific CONTENT

 

Value Driver

 

Cost containment by new efficiencies

 

Manufacturing

 

Big Pharma Drug Production

J&J, Roche, Novartis, Pfizer, Bayer, Merck, GSK, Sanofi, Abbvie, Abbott, Eli Lilly, Amgen, BMS, Gilead, AstraZeneca, TEVA, BI, NovoNordisk, Allergen, Takeda, Shire, Celgene, Biogen

 

Education Private & Public Institutions

 

Medical Education

 

250 Medical Schools in the US & Medical Schools in the European Community

Financial Sector

 

Health Care Insurers

 

United Health, Kaiser Permanente & BlueCross/BlueShield, SelectHealth/Intermountain HC

Education Private & Public Institutions

 

Online Certifications and Degrees

 

Coursera &

MOOC

 

Media

 

Health Care Services (Contract-based Outsourcing)

 

Top 10 on List of Global and US-based CRO & CRA

 

Media

 

Content-driven:

 

(c) Medical and Pharma Associations (a) Global Biotech & Pharmaceutical Conference Organizers

 

@@@@@ older version

Business Function Value Drivers FINANCIAL SECTOR INFORMATION TECHNOLOGY
Holding Companies & Investment Bankers Health Care Insurers Cloud-based Cloud & Server-based
Product Marketing Revenue

generation

by pene-

tration of

multiple

markets

simulta-

neously,

exploit economic benefits from

internal

vertical

integration,

product

differentiation

and

diversification

across product

lines and

markets

Internet Brands of KKR, Temasek,

New Mountain Capital (NMC),

Generex,

 

Product Development (a) Software

Application development

(b) product repurposing

(c) Beta Testing

or Clinical Trials

Amazon Web Services (AWS),   Alphabet – Verily,   Apple-Health,   IBM Watson

Illumina

 

Microsoft, Oracle-Health, SAAP
Horizontal Merger  

Change in Organizational

Structure by

acquiring

economies of

scale and

increasing

capacities for

doing same

functions in

bigger scale

Vertical Merger  

Change in

Organization

Structure by

integration of

additional

functionality

to existing

workflows &

production

processes,

capability

augmentation

by new

expertise (R&D, Production,

Marketing) via acquisitions

 

Application of proprietary Intellectual Property & Knowledge dissemination to Members or event Attendees

Creative

scientific

CONTENT

creation

 

Analytics & Discovery: Text Mining Corpus of Article, Books, e-Proceeding

Cost

containment

by new

efficiencies

United Health,

Kaiser

Perma-nente & BlueCross/

BlueShield

 

Business Function Value Drivers MANUFACTURING 
Big Pharma Drug Production Scientific Publishing Journals & Book Production
Product Marketing Revenue generation by penetration of multiple markets simultaneously, exploit economic benefits from internal vertical integration, product differentiation and diversification across product lines and  markets
Product Development (a) Software Application development

(b) product repurposing

(c) Beta Testing or Clinical Trials

J&J, Roche, Novartis, Pfizer, Bayer, Merck, GSK, Sanofi, Abbvie, Abbott, Eli Lilly, Amgen, BMS, Gilead, AstraZeneca, TEVA, BI, NovoNordisk, Allergen, Takeda, Shire, Celgene, Biogen

 

Horizontal Merger Change in Organizational Structure by acquiring economies of scale and increasing capacities for doing same functions in bigger scale Wolters Kluwer, Elsevier, John Wiley, CHI
Vertical Merger Change in Organization Structure by integration of additional functionality to existing workflows & production processes, capability augmentation by new expertise (R&D, Production, Marketing) via acquisitions J&J, Roche, Novartis, Pfizer, Bayer, Merck, GSK, Sanofi, Abbvie, Abbott, Eli Lilly, Amgen, BMS, Gilead, AstraZeneca, TEVA, BI, NovoNordisk, Allergen, Takeda, Shire, Celgene, Biogen
Application of proprietary Intellectual Property & Knowledge dissemination to Members or event Attendees Creative scientific CONTENT creation
 

Analytics & Discovery: Text Mining Corpus of Article, Books, e-Proceeding

Cost containment by new efficiencies

 

Business Function Value Drivers EDUCATION

Private & Public Institutions

MEDIA
Medical Education Online Certifi-cations and Degrees Health

Care Services (Contract-based Out-sourcing)

Content

-driven

Product Marketing Revenue generation

by penetration of multiple markets simulta-neously, exploit economic benefits

from internal vertical integration, product differentiation and diversifi-cation across product lines and   markets

Product Development (a) Software

Application development

(b) product repurposing

(c) Beta

Testing or Clinical Trials

(b) Infor-

mation Syndica

tors

(Reuters Clarivate

&

Springer)

Horizontal Merger  

Change in Organizational Structure by acquiring economies of scale and increasing capacities for doing same functions in bigger scale

(d) Internet Health Care Media (MedScape, UptoDate)
Vertical Merger  

Change in

Organization

Structure by

integration of

additional

functionality

to existing

workflows &

production

processes,

capability

augmentation

by new

expertise (R&D, Production,

Marketing) via acquisitions

 

Application

of

proprietary Intellectual Property

&

Knowledge dissemi-nation to Members or event Attendees

Creative

scientific

CONTENT

creation

250 Medical Schools in the US & Medical Schools in the European Community Coursera

& MOOC

(c) Medical and Pharma Associations (a) Global Biotech & Pharma-ceutical Conference Organizers
 

Analytics & Discovery: Text Mining Corpus of Article, Books, e-Proceeding

Cost

containment

by new

efficiencies

Top 10 on List of Global and US-based CRO & CRA

 

Three IP Asset Classes: Their Economic Value Potential for

Prospective acquirers

Holding Company and Investment Banker

Potential Use by Acquirer:

Invest in product marketing of three Lines of Business

Class I,II,III

  • Internet Brands of KKR

http://www.kkr.com/

  • Temasek

https://www.temasek.com.sg/en/index.html

  • New Mountain Capital (NMC)

http://www.newmountaincapital.com/

  • Generex

http://www.generex.com/

 

Information Technology Companies – Health Care

Potential Use by Acquirer:

Use contents in application development

Class I,II,III 

  • Amazon Web Services (AWS)
  • Google- Verily
  • Apple Health
  • Microsoft
  • IBM-Watson
  • Oracle Healthcare
  • Illumina

 

Scientific Publishers

Potential Use by Acquirer:

Horizontal merger

Class I,II,III 

  • Wolters Kluwer
  • Elsevier
  • John Wiley
  • CHI

 

Big Pharma

Potential Use by Acquirer:

Vertical Integration with a production factor

Class I,II,III

1. Drug Discovery Process

2. Clinical Trial

3. Drug Repurposing

https://pharmaceuticalintelligence.com/2019/02/14/drug-repurposing-hub-library-broadinstitute-mit-harvard/

  • J&J
  • Roche
  • Novartis
  • Pfizer
  • Bayer
  • Merck
  • GSK
  • Sanofi
  • Abbvie
  • Abbott
  • Eli Lilly
  • Amgen
  • BMS
  • Gilead
  • AstraZeneca
  • TEVA
  • BI
  • NovoNordisk
  • Allergen
  • Takeda
  • Shire
  • Celgene
  • Biogen

 

Internet Health Care Media

 Potential Use by Acquirer:

Horizontal merger

Class I,II,III

  • MedScape

–        676,000 active US Physicians

–        2,000,000 active US HCP’s (non-Physicians)

  • UptoDate

 

Education

Potential Use by Acquirer:

Content is King

Class I,II

  • MOOC
  • Coursera

 

Health Insurance Companies & HMOs

Potential Use by Acquirer:

Optimization of Treatment: Efficacy vs cost of treatment

Class I,II,III

  • United Health
  • Kaiser Permanente
  • BC/BS

 

Medical and Pharma Associations

Potential Use by Acquirer:

Information for Members

Class I,II,III 

  • Chinese College of Cardiology – 350,000 MDs
  • Chinese College of Oncology
  • Germany
  • Japan
  • India
  • Canada

 

  Medical Education

Potential Use by Acquirer:

Content is King

Class I,II,III

  • 250 Medical Schools in the US
  • Europe

In 2019, Class II, e-Books are in Use in Medical Schools in the State of Pennsylvania for curriculum development:

Series A: Volume 3 – Epigenetics, Genetics and Genomics [Jefferson Medical School, Philadelphia]

Series B: Volume 1 –  Genomics & Personalized Medicine [Temple University, Philadelphia]

Series C: Volume 1,2 – Cancer [Temple University, Philadelphia]

Series E: Volume 1 – Voices of Patients  [Jefferson Medical School, Philadelphia]

 

Information Syndicators

Potential Use by Acquirer:

Text Mining

Class I,II,III

  • US – Reuters’ Clarivate

They are operating in the same arena.

They can use our system to other domains.

They can develop it as part of their comprehensive offer.

New connections and ideas they will bring on board.

  • Europe – Springer

 

Global Biotech & Pharmaceutical Conference Organizers

Potential Use by Acquirer:

Information for Attendees

Class I,II,III

  • US – Cambridge Healthtech Institute – Class I,II,III
  • BIO Asia International Conference – BIO
  • CPhI North America 2019 | No.1 Biotech Conference‎
  • 25th Asia Pacific Biotechnology Congress
  • BIO-Europe Spring® | Vienna, Austria. Mar 25-27‎
  • BioTech Conference 2019 London | UK. May 7-8. 

CRO & CRA

Potential Use by Acquirer:

Text Mining for Indication and off label in Clinical Trial Design and After Market Efficacy Monitoring

Class I,II,III 

  • Top 10 on List of CRO in the US
  • Top 10 on List of Global CRO

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Print
  • Email

Like this:

Like Loading...

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,071 other followers

  • Recent Posts

    • The top 10 medtech M&A deals of 2020 April 14, 2021
    • Mechanism of Thrombosis with AstraZeneca and J & J Vaccines: Expert Opinion by Kate Chander Chiang & Ajay Gupta, MD April 14, 2021
    • Fighting Chaos with Care, community trust, engagement must be cornerstones of pandemic response April 13, 2021
    • Linking Thrombotic Thrombocytopenia to ChAdOx1 nCov-19 Vaccination, AstraZeneca April 12, 2021
    • Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure. April 10, 2021
    • Embryogenesis in Mechanical Womb April 8, 2021
    • COVID-19 Sequel: Neurological Impact of Social isolation been linked to poorer physical and mental health March 30, 2021
    • T cells recognize recent SARS-CoV-2 variants March 30, 2021
    • Top Industrialization Challenges of Gene Therapy Manufacturing March 29, 2021
    • COVID-related financial losses at Mass General Brigham March 28, 2021
  • Archives

  • Categories

  • Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.com
    • 2012pharmaceutical
    • Amandeep Kaur
    • Aashir Awan, Phd
    • Adina Hazan
    • Alan F. Kaul, PharmD., MS, MBA, FCCP
    • alexcrystal6
    • anamikasarkar
    • apreconasia
    • aviralvatsa
    • David Orchard-Webb, PhD
    • danutdaagmailcom
    • Demet Sag, Ph.D., CRA, GCP
    • Daniel Menzin
    • Dror Nir
    • dsmolyar
    • evelinacohn
    • Gail S Thornton
    • Irina Robu
    • jayzmit48
    • jdpmd
    • jshertok
    • kellyperlman
    • Ed Kislauskis
    • larryhbern
    • Madison Davis
    • marzankhan
    • megbaker58
    • ofermar2020
    • Dr. Pati
    • pkandala
    • Rosalind Codrington, PhD
    • ritusaxena
    • Rick Mandahl
    • sjwilliamspa
    • stuartlpbi
    • Dr. Sudipta Saha
    • tildabarliya
    • zraviv06
    • zs22

Blog at WordPress.com.

WPThemes.


loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
<span>%d</span> bloggers like this: